Prospector Partners LLC Has $16.81 Million Position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Prospector Partners LLC increased its position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 76.7% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 674,970 shares of the medical instruments supplier’s stock after buying an additional 293,030 shares during the quarter. DENTSPLY SIRONA accounts for 1.9% of Prospector Partners LLC’s portfolio, making the stock its 18th biggest holding. Prospector Partners LLC owned approximately 0.33% of DENTSPLY SIRONA worth $16,814,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in XRAY. Principal Securities Inc. bought a new stake in shares of DENTSPLY SIRONA in the 4th quarter valued at approximately $26,000. LRI Investments LLC raised its stake in DENTSPLY SIRONA by 82.7% during the second quarter. LRI Investments LLC now owns 1,246 shares of the medical instruments supplier’s stock worth $31,000 after acquiring an additional 564 shares in the last quarter. Rothschild Investment LLC bought a new position in shares of DENTSPLY SIRONA during the second quarter valued at $32,000. Central Pacific Bank Trust Division acquired a new stake in shares of DENTSPLY SIRONA in the 1st quarter valued at $64,000. Finally, Mather Group LLC. bought a new stake in shares of DENTSPLY SIRONA in the 1st quarter worth about $72,000. 95.70% of the stock is currently owned by institutional investors.

DENTSPLY SIRONA Trading Down 2.3 %

Shares of XRAY opened at $26.29 on Friday. The stock’s fifty day simple moving average is $25.56 and its 200-day simple moving average is $27.86. The firm has a market capitalization of $5.46 billion, a PE ratio of -59.75, a price-to-earnings-growth ratio of 1.25 and a beta of 1.00. DENTSPLY SIRONA Inc. has a 12-month low of $23.58 and a 12-month high of $37.60. The company has a quick ratio of 0.87, a current ratio of 1.33 and a debt-to-equity ratio of 0.57.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its earnings results on Wednesday, July 31st. The medical instruments supplier reported $0.49 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.50 by ($0.01). DENTSPLY SIRONA had a negative net margin of 4.75% and a positive return on equity of 11.86%. The business had revenue of $984.00 million for the quarter, compared to analyst estimates of $993.61 million. During the same quarter in the previous year, the company posted $0.51 earnings per share. The business’s revenue for the quarter was down 4.3% on a year-over-year basis. As a group, research analysts predict that DENTSPLY SIRONA Inc. will post 1.99 earnings per share for the current year.

DENTSPLY SIRONA Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 11th. Shareholders of record on Friday, September 27th will be issued a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a yield of 2.43%. The ex-dividend date of this dividend is Friday, September 27th. DENTSPLY SIRONA’s dividend payout ratio is presently -145.45%.

Analysts Set New Price Targets

Several equities analysts recently issued reports on XRAY shares. Barrington Research reissued an “outperform” rating and set a $36.00 price target on shares of DENTSPLY SIRONA in a report on Friday. Stifel Nicolaus cut their target price on shares of DENTSPLY SIRONA from $30.00 to $28.00 and set a “hold” rating for the company in a research note on Thursday, July 18th. Needham & Company LLC reissued a “buy” rating and issued a $34.00 target price on shares of DENTSPLY SIRONA in a report on Tuesday, August 20th. Robert W. Baird dropped their price target on DENTSPLY SIRONA from $33.00 to $31.00 and set a “neutral” rating for the company in a report on Monday, July 22nd. Finally, Evercore ISI reduced their price objective on DENTSPLY SIRONA from $28.00 to $27.00 and set an “outperform” rating on the stock in a research note on Tuesday, July 9th. Five analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to MarketBeat, DENTSPLY SIRONA presently has an average rating of “Moderate Buy” and an average target price of $33.22.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.